𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Growth inhibition of colon cancer cells by polyisoprenylated benzophenones is associated with induction of the endoplasmic reticulum response

✍ Scribed by Petr Protiva; Michael E. Hopkins; Scott Baggett; Hui Yang; Martin Lipkin; Peter R. Holt; Edward J. Kennelly; Weinstein I. Bernard


Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
396 KB
Volume
123
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Polyisoprenylated benzophenones derived from Garcinia xanthochymus have cytotoxic activity in vitro and antitumor activity in rodent models, but the mechanism is unknown. The purpose of our study was to examine in parallel molecular pathways that are targeted by 3 Garcinia‐derived benzophenones‐xanthochymol (X), guttiferone E (GE) and guttiferone H (GH), in 3 human colon cancer cell lines, HCT116, HT29 and SW480. The IC50 concentrations were determined and the cells were then treated with X, GE or GH at their respective IC50 or IC50x2 concentrations. Effects on the cell cycle, mitochondrial membrane potential and apoptosis were assessed by flow cytometry and caspase activation. Changes in gene expression were assessed with Illumina 24 K gene arrays. We found that X, GE and GH induced loss of mitochondrial membrane potential and G1 arrest at their IC50 concentrations and induced caspase activation at IC50 × 2 concentrations. An analysis of the changes in gene expression revealed that with all 3 compounds and all 3 cell lines there was a marked increase in expression of several genes, including XBP1, ATF4 and DDIT3/CHOP, which are components of the endoplasmic reticulum stress response. The DDIT4/REDD1 gene, an inhibitor of the mTOR survival pathway, was also up‐regulated. Therefore, X, GE and GH appear to inhibit the growth of human colon cancer cells, at least in part, by activating the endoplasmic reticulum stress response and inhibiting the mTOR cell survival pathway. These combined effects may contribute to the anticancer activity of these novel compounds. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Celecoxib-induced growth inhibition in S
✍ Jae-Won Soh; Julhash U. Kazi; Han Li; W. Joseph Thompson; I. Bernard Weinstein 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

## Abstract Although it is often assumed that the antitumor effects of nonsteroidal anti‐inflammatory drugs (NSAIDs) are due to inhibition of cyclooxgenase (COX) activity, specifically COX‐2, there is accumulating evidence that COX‐2 independent mechanisms can also play an important role. Studies w

Prostate cancer cell growth inhibition b
✍ Rohlff, Christian; Blagosklonny, Mikhail V.; Kyle, Edward; Kesari, Anuradha; Yi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 2 views

BACKGROUND. Inhibition of protein kinase C (PKC) and modulation of transforming growth factor-␤ (TGF-␤) are both associated with tamoxifen treatment, and both appear to be important in the regulation of prostate cancer cell growth. Investigations were performed which sought to measure the efficacy,

The growth inhibitory effect of actein o
✍ Linda Saxe Einbond; Tao Su; Hsan-au Wu; Richard Friedman; Xiaomei Wang; Alejandr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 547 KB

## Abstract Previous studies indicate that the triterpene glycoside actein from the herb black cohosh inhibits growth of human breast cancer cells. This study seeks to identify genes altered in human breast cancer cells by treatment with actein, using gene expression analysis. We treated MDA‐MB‐453

Induction of cell growth by insulin and
✍ Le�n, Yolanda; Sanz, Carmen; Gir�ldez, Fernando; Varela-Nieto, Isabel 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

The present report investigates the cellular mechanisms involved in the regulation of cell proliferation by insulin and insulin-like growth factor-I (IGF-I) in the developing inner ear. The results show that insulin and IGF-I stimulate cell proliferation in the otic vesicle. This effect is associate

Inhibition of proliferation and inductio
✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant